I think assuming the technology works at all will get you into a lot of trouble in the healthcare investing arena. I have questions. Do you have the answers? How can the distinct 'ligands' that the micelles are bound to be manufactured? How large are they? What's the structure? These are simple questions. Most drugs have a molecular structure. If they don't, they're the large antibodies which are very tough to characterize. If this product is that small, it should be rather simple to display. What does it look like, chemically?
News 
Market Data 
Discover 
AI
